Cognito Therapeutics
Shawn Lockhart/CDC via AP
Mayara Klingner / EyeEm / Getty Images
David Kasnic/The Washington Post/Getty Images
In a study out this week, scientists describe a novel experimental pill that may be able to help patients with a difficult-to-treat form of leukemia. Nearly half of patients in the Phase I trial responded to the treatment, called revumenib, while about a third experienced a complete remission of their cancer. More…
New research has found a possible link between having high levels of caffeine in your blood and a reduced risk of high body fat and type 2 diabetes. The authors say that clinical trials should be done to confirm whether calorie-free caffeinated drinks can help prevent these conditions.
In a paper out this week, scientists argue that a common industrial chemical is contributing to Parkinson’s disease. The chemical is called trichloroethylene, or TCE. And while some states have recently banned its use, TCE remains widely present throughout the U.S.
AI isn’t just good for writing term papers or clickbait financial explainers; it could help save lives in the medical field.